Staff Services Student Enterprise

Edinburgh finalists at Scotland's Life Sciences Awards 2025

Bioliberty co-founder and CEO Rowan Armstrong, School of Engineering graduate, Extraordinary Talent finalist
 
19 Feb 2025

Three University of Edinburgh companies have been named finalists in Scotland’s Life Sciences Awards 2025.

The awards celebrate the leading players in Scotland’s vibrant life sciences industry and recognise those who have contributed most to the sector in the last year.

In the Global Export Impact category is biotech company Dyneval, which provides the UK’s only portable technology for cattle semen analysis, designed to help boost conception rates. Founder and CEO Dr Tiffany Wood is a Senior Academic Researcher at the School of Physics and Astronomy and CTO Dr Vincent Martinez is a Research Fellow.

In December, Dyneval secured investment of £516,000, led by Lifted Ventures, unlocking an £85,000 Scottish Enterprise grant, and Dr Wood received an Innovate UK Women in Innovation award. Dyneval also completed the University’s AI Accelerator programme.

Previous Life Sciences winner, regenerative medicine company Roslin CT, which span out of the Roslin Institute in 2006, is up for the Outstanding Skills Development Award. The company, based at the Edinburgh Bioquarter, develops and manufactures cell therapies that can treat cancer and genetic disorders.

And the four founders of student startup Bioliberty – School of Engineering graduates Rowan Armstrong (CEO) and Ross O’Hanlon (CTO) and co-founders Conan Bradley and Shéa Quinn – are finalists in the Extraordinary Talent award.

Another AI Accelerator alumnus, Bioliberty began exporting their main products to the US last year: an exoskeleton robotic glove called Lifeglov that helps rehabilitate people with reduced hand strength, and Lifehub, a digital therapy platform that helps develop natural hand strength.

The company have received pre-seed and seed funding from the University’s in-house venture investment fund Old College Capital (OCC) and remain part of OCC’s portfolio.

Dr Andrea Taylor, CEO of Edinburgh Innovations, said:

The Scottish life sciences sector is world-leading in areas such as regenerative medicine and agritech, with academics and companies combining research expertise with cutting-edge data and technical facilities, such as at the Edinburgh Bioquarter.
At Edinburgh Innovations, we provide the commercialisation expertise, and we’re extremely proud to have helped these fantastic founders get their companies off the ground, and to continue to support them, such as through OCC. We wish them all luck on March 13th. ”

Scotland’s Life Sciences Annual Awards and Dinner will take place on Thursday March 13th at the Hilton Glasgow Central.

Related links

AI Accelerator

Bioliberty

Dyneval

Roslin CT